Previous close | 8.95 |
Open | 9.00 |
Bid | 8.95 x N/A |
Ask | 9.25 x N/A |
Day's range | 9.00 - 9.00 |
52-week range | 8.85 - 20.80 |
Volume | |
Avg. volume | 3 |
Market cap | 6.192B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 23.08 |
EPS (TTM) | 0.39 |
Earnings date | 26 July 2024 - 30 July 2024 |
Forward dividend & yield | 0.25 (2.78%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
M3 Wake Research, a leading fully integrated network of clinical research sites and one of North America's largest providers of Phase I-IV clinical trials, is expanding operations into Charleston, SC with the opening of a clinical research practice. Operating as Charleston Clinical Trials, LLC, the new center is led by Donald Hurley, DO, and located at 2270 Ashley Crossing Drive in Charleston.